Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect

Details for Australian Patent Application No. 2002235743 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Peukert, Stefan; Hemmerle, Horst; Kleemann, Heinz-Werner; Brendel, Joachim

Agent Watermark

Pub. Number AU-B-2002235743

PCT Pub. Number WO02/48131

Priority 10061876 12.12.00 DE

Filing date 29 November 2001

Wipo publication date 24 June 2002

Acceptance publication date 20 July 2006

International Classifications

C07D 307/68 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

20 July 2006 Application Accepted

  Published as AU-B-2002235743

16 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002235744-RNA interference mediating small RNA molecules

2002235742-INSTRUCTIONAL METHOD AND SYSTEM USING WIRELESS COMMUNICATION